Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease

[1]  J. Di Paola,et al.  Mutations in the D'D3 region of VWF traditionally associated with type 1 VWD lead to quantitative and qualitative deficiencies of VWF. , 2016, Thrombosis research.

[2]  C. Denis,et al.  A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease , 2016, Medicine.

[3]  J. Gill,et al.  Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. , 2015, Blood.

[4]  Richard J. R. Kelwick,et al.  The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family , 2015, Genome Biology.

[5]  I. Kurnaz.  Protein Production and Purification , 2015 .

[6]  J. Eikenboom,et al.  von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease. , 2015, Blood.

[7]  X. Zheng.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. , 2015, Annual review of medicine.

[8]  N. Tolia,et al.  Allosteric activation of ADAMTS13 by von Willebrand factor , 2014, Proceedings of the National Academy of Sciences.

[9]  C. Lynch,et al.  Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF. , 2014, Blood.

[10]  E. Berber.  The Molecular Genetics of von Willebrand Disease , 2012, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[11]  M. I. Hassan,et al.  Characterisation of mutations and molecular studies of type 2 von Willebrand disease , 2012, Thrombosis and Haemostasis.

[12]  W. Thomas,et al.  Structural Basis of Type 2A von Willebrand Disease Investigated by Molecular Dynamics Simulations and Experiments , 2012, PloS one.

[13]  J. Gill,et al.  Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage. , 2012, Blood.

[14]  P. Mannucci,et al.  Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients , 2012, Journal of thrombosis and haemostasis : JTH.

[15]  E. Wee.  Von Willebrand Disease in the Netherlands , 2011 .

[16]  D. Lane,et al.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. , 2011, Blood.

[17]  D. Lillicrap,et al.  Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models. , 2011, Blood.

[18]  Christine A. Lee,et al.  Von Willebrand Disease: Basic and Clinical Aspects , 2011 .

[19]  D. Lane,et al.  The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity. , 2010, Blood.

[20]  R. Schneppenheim,et al.  A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE. , 2010, Blood.

[21]  A. Goodeve.  The genetic basis of von Willebrand disease. , 2010, Blood reviews.

[22]  P. Lenting,et al.  A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. , 2009, Blood.

[23]  P. Mannucci,et al.  Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization , 2009, Journal of thrombosis and haemostasis : JTH.

[24]  F. Rodeghiero,et al.  Autosomal Recessive von Willebrand Disease Type 1 or 2 due to Homozygous or Compound Heterozygous Mutations in the von Willebrand Factor Gene , 2009, Acta Haematologica.

[25]  L. O'Brien,et al.  ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor , 2008, British journal of haematology.

[26]  K. Shim,et al.  Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. , 2008, Blood.

[27]  D. Bowen,et al.  The association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13. , 2007, Haematologica.

[28]  P. Mannucci,et al.  Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor , 2006, Journal of thrombosis and haemostasis : JTH.

[29]  Z. Berneman,et al.  Characterization of Recessive Severe Type 1 and 3 von Willebrand Disease (VWD), Asymptomatic Heterozygous Carriers Versus Bloodgroup O-Related von Willebrand Factor Deficiency, and Dominant Type 1 VWD , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[30]  R. Schneppenheim,et al.  Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis. , 2006, Blood.

[31]  D. Lane,et al.  ADAMTS13 Substrate Recognition of von Willebrand Factor A2 Domain* , 2006, Journal of Biological Chemistry.

[32]  Rajiv K. Saxena,et al.  Gene conversions are a common cause of von Willebrand disease , 2005, British journal of haematology.

[33]  P. Collins,et al.  An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. , 2004, Blood.

[34]  J. Sutherland,et al.  Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. , 2003, Blood.

[35]  J. Sadler,et al.  Von Willebrand disease type 1: a diagnosis in search of a disease. , 2003, Blood.

[36]  J. Eikenboom,et al.  Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. , 2001, Blood.

[37]  P. Mannucci.  How I treat patients with von Willebrand disease. , 2001, Blood.

[38]  P. Mannucci.  Treatment of von Willebrand's disease , 1997, Journal of internal medicine. Supplement.

[39]  J. Stoddart,et al.  Clearance of normal and type 2A von Willebrand factor in the rat. , 1996, Blood.

[40]  J. Ware,et al.  Conformational Changes in the A1 Domain of von Willebrand Factor Modulating the Interaction with Platelet Glycoprotein Ib (*) , 1996, The Journal of Biological Chemistry.

[41]  F. Collins,et al.  Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr). , 1991, American journal of human genetics.

[42]  W. Marks,et al.  The effect of ABO blood group on the diagnosis of von Willebrand disease. , 1987, Blood.

[43]  Obi-Wan Kenobi.  von Willebrand factor , Jedi knight of the bloodstream , 2014 .

[44]  P. Mannucci,et al.  A Sensitive Ristocetin Co-factor Activity Assay with Recombinant Glycoprotein Ibα for the Diagnosis of Patients with Low Von Willebrand Factor Levels , 2022 .